Ann Arbor, Mich. (August 31, 2010) — Compendia Bioscience, Inc. today announced the award of $1.3 million in SBIR Fast Track funds to incorporate micro-RNA data and analyses into the Oncomine platform.
Despite the growing accumulation of micro-RNA profiling data in a range of cancer-related studies, it is nearly impossible for a cancer biologist to survey the differential expression of an individual micro-RNA or micro-RNA signature across all published datasets, or to integrate knowledge about micro-RNA expression patterns with other relevant biological phenomena such as gene expression, copy number, and mutation data.
This project will systematically capture, curate, and analyze the novel micro-RNA data type in a standardized way and provide the data and analyses in an interface that promotes ongoing inquiry. This effort will require significant technical innovation to capture, organize, and present data that is both biologically and technically complex in a way that is rapidly comprehensible to the cancer biologist.
For additional information regarding this announcement, please contact:
Chief Business Officer, Compendia Bioscience
Phone: (734) 945-6344